Search - tctmd.com

Displaying 681 - 700 of 1176

Sort: Relevancy | Date

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Industry News

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

April 04, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

Caitlin E. Cox

April 02, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

News Industry News

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

April 01, 2016

News Opinion Fellow Talk

Let Diagnostics Be Your Guide: Nine Tips For Successful Coronary Angiographic Assessment

Henry Quevedo, MD

March 23, 2016

News Industry News

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

March 16, 2016

News Industry News

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

March 06, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2016

Shelley Wood

February 28, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

合并左主干病变时不应排除 TAVR

L.A. McKeown

February 22, 2016

News Daily News

La Enfermedad de Tronco Coronario Izdo. Co-existente No Debería de Descartar Intervenciones TAVR

L.A. McKeown

February 22, 2016

News Daily News

Coexisting Left Main Disease Should Not Rule Out TAVR

L.A. McKeown

February 22, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Daily News

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

L.A. McKeown

February 16, 2016

News Daily News

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

L.A. McKeown

February 15, 2016

News Daily News

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

Michael O'Riordan

February 08, 2016

News Daily News

FDA Grants Go-Ahead for Low-Risk TAVR Study

Shelley Wood

January 14, 2016

Advertisement

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

LivaNova PLC Announces the First Patient Enrolled in the PERSIST-AVR Trial

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

When Chosen Wisely, 90-Year-Olds Do Well After TAVR

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

First Patients Enrolled in Medtronic Trial in Low-Risk Aortic Stenosis Patients

Let Diagnostics Be Your Guide: Nine Tips For Successful Coronary Angiographic Assessment

Edwards Lifesciences Receives Approval For SAPIEN 3 Valve In Japan

Medtronic Enrolls First Patients in Clinical Study to Evaluate the CoreValve(TM) Evolut(TM) R System in 'Real-World' Setting

TCTMD’s Top 10 Most Popular Stories for February 2016

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

合并左主干病变时不应排除 TAVR

La Enfermedad de Tronco Coronario Izdo. Co-existente No Debería de Descartar Intervenciones TAVR

Coexisting Left Main Disease Should Not Rule Out TAVR

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Anthracycline-Based Chemotherapy Linked to Valve Disease, Even in Absence of Radiation

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

Subclinical Changes in Valve Hemodynamics Observed in TAVR Patients

FDA Grants Go-Ahead for Low-Risk TAVR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content